Lokich J
Cancer Center of Boston, MA 02120.
Am J Clin Oncol. 1994 Apr;17(2):157-9.
A patient with metastatic adamantinoma from the tibia is described, in whom the biologic behavior of the tumor and the clinical course that evolved was typical. Tumor regression was observed on two separate occasions to a combination chemotherapeutic regimen of etoposide plus cisplatin or carboplatin.